Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
69.00
Ask:
71.00
Spread: 2.00 (2.899%)
Market Cap: £318.58m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Final Results

12 Dec 2008 12:06

RNS Number : 0481K
Avacta Group PLC
12 December 2008
 



Avacta Group plc

Audited Results for the year to 31 July 2008

On 4 November 2008, Avacta Group plc ("Avacta", the "Group" or the "Company") announced its preliminary results for the year to 31 July 2008. The preliminary results included intangible assets of £7,144,000 and an other reserve of £1,834,000 reflecting the application of reverse acquisition accounting of the transaction whereby Avacta Limited reversed into Avacta Group plc (formerly Readybuy plc) during August 2006. Upon conversion from accounting under United Kingdom Generally Accepted Accounting Practice to International Financial Reporting Standards as adopted by the European Union, it is possible to recognise a different treatment of this transaction within the financial statements, which the Directors believe to be beneficial.

There is no impact on the income statement or the cash flows of the Group in either the current or comparative accounting period

Accordingly, the consolidated balance sheet of the Group has been adjusted from that included within the Preliminary Announcement to reflect this revised treatment resulting in goodwill of £3,563,000 that had been previously recognised within the intangible assets of £7,144,000 now being recognised within the other reserveThe adjusted consolidated balance sheet is included within this announcement. 

There are no other changes to the Preliminary Announcement.

The Company's full Annual Report & Accounts are available on its website at www.avacta.com

Enquiries:

Avacta Group plc

087 0835 4367

Alastair Smith, Chief Executive Officer

Tim Sykes, Chief Financial Officer

Daniel Stewart & Company plc

020 7776 6550

Lindsay Mair / Charlotte Stranner

Novum Securities Limited

020 7562 4700

Henry Turcan

Haggie Financial LLP

020 7417 8989

Nicholas Nelson / Kathy Boate

   

   Consolidated Balance Sheet as at 31 July 2008

2008

2007

£000

£000

Non-current assets

Property, plant & equipment

290

148

Intangible assets

3,581

-

-------------

------------

3,871

148

-------------

------------

Current assets

Trade and other receivables

92

170

Income taxes

84

-

Cash and cash equivalents

1,097

2,527

-------------

------------

1,273

2,697

-------------

------------

Total assets

5,144

2,845

-------------

------------

Current liabilities

Trade and other payables

(234)

(164)

Finance lease obligations

(11)

(11)

-------------

------------

(245)

(175)

-------------

------------

Non-current liabilities

Finance lease obligations

(30)

(41)

-------------

------------

(30)

(41)

-------------

------------

Total liabilities

(275)

(216)

-------------

------------

Net assets

4,869

2,629

-------------

------------

Equity attributable to equity holders of the Company

Called up share capital

900

856

Share premium account

6,524

4,882

Other reserve

(1,729)

(1,729)

Capital reserve

1,899

-

Retained earnings

(2,725)

(1,380)

-------------

------------

Total equity

4,869

2,629

-------------

------------

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR EAAAAFEDPFFE
Date   Source Headline
15th Jun 20202:05 pmRNSSecond Price Monitoring Extn
15th Jun 20202:00 pmRNSPrice Monitoring Extension
15th Jun 202011:05 amRNSSecond Price Monitoring Extn
15th Jun 202011:00 amRNSPrice Monitoring Extension
12th Jun 20207:00 amRNSHolding(s) in Company
10th Jun 20206:35 pmRNSHolding(s) in Company
9th Jun 20207:01 amRNSInvestor Presentation
9th Jun 20207:00 amRNSUpdate on COVID-19 Test Development with Adeptrix
8th Jun 20204:15 pmRNSPosting of Circular and Notice of General Meeting
4th Jun 20205:16 pmRNSDirector/PDMR Shareholding
4th Jun 20205:15 pmRNSResult of Fundraising
4th Jun 202012:30 pmRNSIncrease in Fundraising
4th Jun 202011:05 amRNSSecond Price Monitoring Extn
4th Jun 202011:00 amRNSPrice Monitoring Extension
4th Jun 20209:05 amRNSSecond Price Monitoring Extn
4th Jun 20209:00 amRNSPrice Monitoring Extension
4th Jun 20207:01 amRNSPrimaryBid.com Offers
4th Jun 20207:00 amRNSProposed Fundraising to raise up to £45 million
28th May 20207:00 amRNSPosting of Annual Report and Notice of AGM
26th May 202011:05 amRNSSecond Price Monitoring Extn
26th May 202011:00 amRNSPrice Monitoring Extension
26th May 20208:06 amRNSIssue of Equity
21st May 20202:05 pmRNSSecond Price Monitoring Extn
21st May 20202:00 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSDistribution Agreement for COVID-19 Antigen Test
15th May 20204:41 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
15th May 20202:06 pmRNSSecond Price Monitoring Extn
15th May 20202:00 pmRNSPrice Monitoring Extension
15th May 202011:06 amRNSSecond Price Monitoring Extn
15th May 202011:00 amRNSPrice Monitoring Extension
15th May 20209:30 amRNSIssue of Equity
15th May 20207:00 amRNSSARS-COV-2 Neutralising Affimers
11th May 20207:00 amRNSAvacta Ships SARS-COV-2 Affimer Reagents
6th May 20207:00 amRNSResults for the period ending 31 December 2019
5th May 20206:15 pmRNSHolding(s) in Company
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSCOVID-19 Antigen Test Collaboration with Adeptrix
27th Apr 20205:30 pmRNSHolding(s) in Company
27th Apr 20205:00 pmRNSHolding(s) in Company
24th Apr 20206:00 pmRNSHolding(s) in Company
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:36 pmRNSPrice Monitoring Extension
24th Apr 20202:05 pmRNSSecond Price Monitoring Extn
24th Apr 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20204:40 pmRNSSecond Price Monitoring Extn
23rd Apr 20204:35 pmRNSPrice Monitoring Extension
23rd Apr 202010:18 amRNSResult of General Meeting
22nd Apr 20202:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.